Literature DB >> 11564989

Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus.

S Carugo1, C Giannattasio, I Calchera, F Paleari, M G Gorgoglione, A Grappiolo, P Gamba, G Rovaris, M Failla, G Mancia.   

Abstract

OBJECTIVE: We have recently observed that in young, normotensive patients with a type I diabetes mellitus and no macro or microvascular complications, large artery structure and function are already altered. This study has been done to assess whether this condition is also characterized by early alterations in cardiac structure and function, and whether these alterations progress with time. DESIGN AND METHODS: In 56 insulin-treated, normotensive uncomplicated type I diabetic patients (age 35.0 +/- 2 years, means +/- SE) in good metabolic control, left ventricular wall thickness and diameter were measured by echocardiography together with left ventricular ejection fraction and diastolic function E/A (ratio between early and late ventricular filling), before and after 23 +/- 1 months. The same measurements were made in 20 age and sex-matched subjects who served as controls (C).
RESULTS: Compared to C, diabetic patients had a significant increase in left ventricular wall (septal plus posterior wall) thickness (+ 8.4%), left ventricular mass index (+ 11%) and h/r ratio (left ventricular wall thickness/ventricular end diastolic diameter, + 16.0%) whereas they showed a reduction of E/A (-6%). In C, all echocardiographic values were unchanged after 2 years. This was the case also for diabetic patients, except for left ventricular ejection fraction and diastolic diameter which showed a significant reduction (-7.2%) and increase (+ 3.8%), respectively, with a reduction of ratio between LV wall thickness and diameter, h/r (-6.8%).
CONCLUSIONS: Uncomplicated type I diabetes mellitus is characterized by early structural and functional cardiac alterations. Some of these alterations show a measurable progression within a relatively short time span.

Entities:  

Mesh:

Year:  2001        PMID: 11564989     DOI: 10.1097/00004872-200109000-00021

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  17 in total

1.  Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy.

Authors:  Aina He; Wenqian Fang; Kun Zhao; Yajun Wang; Jie Li; Chongzhe Yang; Feriel Benadjaoud; Guo-Ping Shi
Journal:  Transl Res       Date:  2019-01-19       Impact factor: 7.012

Review 2.  Diabetic cardiomyopathy: signaling defects and therapeutic approaches.

Authors:  Joseph S Dobrin; Djamel Lebeche
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-03

Review 3.  Diabetic cardiovascular disease: getting to the heart of the matter.

Authors:  Linda R Peterson; Clark R McKenzie; Jean E Schaffer
Journal:  J Cardiovasc Transl Res       Date:  2012-05-26       Impact factor: 4.132

4.  The relationship between flow-mediated dilatation and left ventricular function in type 2 diabetic patients with microalbuminuria.

Authors:  Merih Baykan; Turan Erdogan; Cihangir Erem; Arif Hacihasanoglu; Omer Gedikli; Mehmet Küçükosmanoglu; Sukru Celik; Cihan Orem
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.633

Review 5.  A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy.

Authors:  Xinli Zhang; Chen Chen
Journal:  Endocrine       Date:  2012-02-10       Impact factor: 3.633

Review 6.  Metabolic, structural and biochemical changes in diabetes and the development of heart failure.

Authors:  Kim L Ho; Qutuba G Karwi; David Connolly; Simran Pherwani; Ezra B Ketema; John R Ussher; Gary D Lopaschuk
Journal:  Diabetologia       Date:  2022-01-07       Impact factor: 10.122

Review 7.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patients.

Authors:  Roldano Scognamiglio; Christian Negut; Saula Vigili de Kreuizenberg; Monica Palisi; Antonio Tiengo; Angelo Avogaro
Journal:  Clin Cardiol       Date:  2005-02       Impact factor: 2.882

9.  Diabetic cardiomyopathy: is resistin a culprit?

Authors:  Djamel Lebeche
Journal:  Cardiovasc Diagn Ther       Date:  2015-10

10.  Cardiovascular autonomic nervous system function and aerobic capacity in type 1 diabetes.

Authors:  Harriet Hägglund; Arja Uusitalo; Juha E Peltonen; Anne S Koponen; Jyrki Aho; Suvi Tiinanen; Tapio Seppänen; Mikko Tulppo; Heikki O Tikkanen
Journal:  Front Physiol       Date:  2012-09-07       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.